CTOs on the Move

GloboZymes

www.globozymes.com

 
GloboZymes is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.globozymes.com
  • 6351 Corte Del Abeto Ste 101
    Carlsbad, CA USA 92011
  • Phone: 866.891.0439

Executives

Name Title Contact Details

Similar Companies

Agde

Agde Corp. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Earlens

Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens® Contact Hearing Solution, which directly vibrates the eardrum with a tiny lens in order to activate the natural hearing process. This revolutionary, nonsurgical hearing solution delivers the broadest bandwidth available today and superior sound quality. The Earlens® Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. We believe that people with hearing loss shouldn`t have to think about their hearing in everyday situations. Earlens was designed specifically to address the sound quality and speech understanding complaints that are common among hearing aid wearers and contribute to non-compliance. We make every Earlens device custom-fit for each patient`s unique anatomy and hearing needs, while offering modern features such as Bluetooth streaming.

Sunrise Medical Technology

Sunrise Medical Technology is a Waxahachie, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Argyll Medical Group

Argyll Medical Group is a Chico, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Device Management

GDM's VACS software provides capture capabilities and collaborative tools using typically un-captured but critical visual information between patients, clinicians and medical specialists. VACS helps solve the problems today’s clinicians face relating to increased patient flow, less time available and increased demand for better outcomes. The VACS platform, which includes proprietary management software, digital capture/streaming and mobile applications, provides a new level of “rich media” capture, access, interaction and use of images, video, audio and other data elements. Management is currently focused on expanding the VACS platform internationally, to increase clinical efficiency and bridge the visual information gap in today’s growing clinical collaboration processes